Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Meropenem (250mg)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
1
Price
₹467/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Merotyle 250 Injection is a broad-spectrum carbapenem antibiotic used to treat severe bacterial infections caused by susceptible organisms. It works by inhibiting bacterial cell wall synthesis, effectively eliminating the infection. Meropenem is active against a wide range of Gram-positive and Gram-negative bacteria, including multi-drug-resistant strains. It is particularly effective for infections where other antibiotics fail to deliver adequate results.
This injection is commonly prescribed for severe respiratory tract infections, complicated skin and soft tissue infections, urinary tract infections, intra-abdominal infections, and bacterial meningitis. Its efficacy and safety profile make it a reliable choice for treating life-threatening bacterial infections.
Possible side effects include headache, nausea, vomiting, diarrhea, injection site reactions, and skin rash. Rarely, it may cause allergic reactions, elevated liver enzymes, or seizures. Inform your doctor if any adverse effects persist or worsen.
Used to treat severe and complicated bacterial infections, including those resistant to other antibiotics.
This medication should only be administered under the supervision of a qualified healthcare professional. It is contraindicated in patients with known hypersensitivity to carbapenems or beta-lactam antibiotics. In case of allergic reactions, seek immediate medical attention.
Store below 25°C in a cool, dry place, protected from light. After reconstitution, use immediately or as per the healthcare provider’s advice.
Composition : Meropenem (1000mg) + Sulbactam (500mg)
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (500mg) Injection
Composition : Amikacin (100mg)
Composition : Amikacin (250mg)
Composition : Amikacin (500mg)
Composition : Vancomycin (1000mg) Injection
Composition : Vancomycin (500mg) Injection
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Meropenem 250 mg Injection is a broad-spectrum carbapenem antibiotic used for the treatment of moderate to severe bacterial infections such as pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and hospital-acquired infections. It is a critical-care and hospital injectable antibiotic mainly used in ICUs, emergency wards, and multispecialty hospitals. It is a strong anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital demand and institutional procurement, as injectable antibiotics are essential in infection management protocols. Different strengths like 250 mg are used in varied clinical situations, ensuring steady and repeated consumption in hospital settings.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care injectable and antibiotic segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from hospital-driven demand, ICU usage, and continuous infection management protocols, making it a stable and high-volume pharmaceutical segment when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in critical-care antibiotic injectables can contact Cafoli Lifecare to discuss product availability, hospital supply channels, and PCD pharma franchise opportunities in the anti-infective segment.